HomeDrug Discovery and Development

Drug Discovery and Development

Drug Discovery and Development

ImmuneOncia and Lonza Join Hands to Advance Cancer Treatment Innovation

Pharma Outlook -
Strategic manufacturing partnership supports late-stage development of promising immunotherapy drug Basel, 9 April 2026 – ImmuneOncia Therapeutics, a clinical-stage biopharmaceutical company, has partnered with Lonza,...
Drug Discovery and Development

FDA Approves Foundayo, A Game-Changing Daily Pill for Weight Management

Pharma Outlook -
Eli Lilly’s new oral GLP-1 drug promises easier access, simpler use, and a new future for obesity treatment Washington, D.C., 2 April 2026 – In...
Drug Discovery and Development

Deep Intelligent Pharma Raises Fresh $60 Million to Take AI Into Clinical Trials

Pharma Outlook -
The AI drug discovery unicorn aims to move beyond early research and build fully autonomous intelligence for real-world clinical development. Beijing, 4 February 2026 –...
Drug Discovery and Development

Axol Bioscience Secures $2.8M Funding to Expand US Growth and Scale iPSC Disease Models

Pharma Outlook -
The investment will support advanced human-like cell models for neuroscience, eye, and heart research. Edinburgh, Scotland, 14 January 2026 - Axol Bioscience Ltd. (Axol), a...
Drug Discovery and Development

Fast-Track Approvals, AI Tools, and Billion-Dollar Deals Signal a New Era in Global Biopharma

Pharma Outlook -
From rapid FDA approvals to AI-powered diagnostics and major metabolic partnerships, life sciences innovation is accelerating across drugs, devices, and regulation. New York, US, 13...
123...5Page 1 of 5

Hot Topics

Load more

2026 © Pharma Business Outlook. All rights reserved.

Quick Links

Must Read

Popular Articles